S. Haas

419 total citations
22 papers, 294 citations indexed

About

S. Haas is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, S. Haas has authored 22 papers receiving a total of 294 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Internal Medicine, 10 papers in Cardiology and Cardiovascular Medicine and 7 papers in Surgery. Recurrent topics in S. Haas's work include Venous Thromboembolism Diagnosis and Management (12 papers), Atrial Fibrillation Management and Outcomes (5 papers) and Antiplatelet Therapy and Cardiovascular Diseases (4 papers). S. Haas is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (12 papers), Atrial Fibrillation Management and Outcomes (5 papers) and Antiplatelet Therapy and Cardiovascular Diseases (4 papers). S. Haas collaborates with scholars based in Germany, Austria and United States. S. Haas's co-authors include A.K. Kakkar, H.K. Breddin, J Conard, Jawed Fareed, Grigoris Gerotziafas, Sami Guermazi, Paul A. Carpenter, A. Stemberger, J. J. Michiels and G. Blümel and has published in prestigious journals such as British journal of surgery, Thrombosis and Haemostasis and Journal of Thrombosis and Haemostasis.

In The Last Decade

S. Haas

19 papers receiving 266 citations

Peers

S. Haas

CCM

SURGE

HEMAT

EMS

R. Duce Italy

Esmeralda Filippucci Italy

Chethan Gangireddy United States

Kevin N. Hoffman United States

Gail P. Size United States

U S Burmark Sweden

M Fagola France

Maddalena Miccio Italy

Michel Bellaud France

Lisa Mark United States

R. Duce Italy

S. Haas

152 ×0.7

107 ×0.7

CCM

60 ×0.6

SURGE

36 ×0.4

HEMAT

34 ×1.1

EMS

Citations per year, relative to S. Haas S. Haas (= 1×) peers R. Duce

Countries citing papers authored by S. Haas

Since Specialization

Citations

This map shows the geographic impact of S. Haas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Haas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Haas more than expected).

Fields of papers citing papers by S. Haas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Haas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Haas. The network helps show where S. Haas may publish in the future.

Co-authorship network of co-authors of S. Haas

This figure shows the co-authorship network connecting the top 25 collaborators of S. Haas. A scholar is included among the top collaborators of S. Haas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Haas. S. Haas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Provenzano, David, Joseph Atallah, Binit Shah, et al.. (2025). Assessment of real-world, prospective outcomes in patients treated with lumbar radiofrequency ablation for chronic pain (RAPID). Interventional Pain Medicine. 4(2). 100576–100576.

Bauersachs, Rupert, E. Sebastian Debus, Meinrad Gawaz, et al.. (2012). Therapie mit Dabigatran. Hämostaseologie. 32(4). 294–305. 21 indexed citations

Friedman, R. J., et al.. (2010). RIVAROXABAN FOR PREVENTION OF VENOUS THROMBOEMBOLISM AFTER TOTAL HIP REPLACEMENT: IMPACT ON HEALTHCARE COSTS BASED ON THE RECORD1 STUDY. 289–289. 1 indexed citations

Agnelli, Giancarlo, Alexander Gallus, Samuel Z. Goldhaber, et al.. (2006). Treatment of acute, symptomatic, proximal deep vein thrombosis with the oral, direct Factor Xa inhibitor rivaroxaban (BAY 59-7939) - the ODIXa-DVT dose-ranging study. 9 indexed citations

Kakkar, A.K., et al.. (2004). Compliance with recommended prophylaxis for venous thromboembolism: improving the use and rate of uptake of clinical practice guidelines. Journal of Thrombosis and Haemostasis. 2(2). 221–227. 73 indexed citations

Haas, S.. (2002). Aprotinin – a Blood-Saving Substance. Transfusion Medicine and Hemotherapy. 29(3). 151–155. 5 indexed citations

Breddin, H.K., et al.. (2001). Topical mucopolysaccharide polysulfate (MPS) in the treatment of thrombophlebitis – A critical review. Phlebologie. 30(6). 132–139. 6 indexed citations

Haas, S.. (1997). Prävention, Diagnostik und Therapie von Thrombosen in der Orthopädie und Unfallchirurgie. Der Orthopäde. 26(12). 1062–1062. 3 indexed citations

Haas, S.. (1997). [Thrombosis in trauma and orthopedic surgery. Prevention, diagnosis, therapy].. PubMed. 100(4). 307–19. 4 indexed citations

10.

Haas, S.. (1996). The Role of Low-Molecular-Weight Heparins in the Prevention of Venous Thrombosis in Surgery with Special Reference to Enoxaparin. Pathophysiology of Haemostasis and Thrombosis. 26(Suppl. 2). 39–48. 8 indexed citations

11.

Haas, S., et al.. (1993). Prevention of postoperative thromboembolism with Enoxaparin in general surgery: a German multicenter trial.. PubMed. 19 Suppl 1. 164–73. 28 indexed citations

12.

Haas, S. & Peter Haas. (1993). [Observations on pathophysiology and pathogenesis of venous thrombosis].. PubMed. 22(2). 94–9. 1 indexed citations

13.

Leyvraz, P.-F., et al.. (1992). Thromboembolic prophylaxis in total hip replacement: A comparison between the low molecular weight heparinoid Lomoparan and heparindihydroergotamine. British journal of surgery. 79(9). 911–914. 26 indexed citations

14.

Haas, S. & Peter Haas. (1992). [Prevention of thromboembolism in trauma surgery and orthopedics].. PubMed. 63(4). 271–5. 4 indexed citations

15.

Haas, S. & G. Blümel. (1988). Prophylaxis of Thromboembolism with Various Low-Molecular-Weight Heparins. Pathophysiology of Haemostasis and Thrombosis. 18(Suppl. 3). 82–87. 2 indexed citations

16.

Haas, S., et al.. (1987). MEASUREMENT OF ELASTASE-INDUCED FIBRINOGEN-DERIVED PEPTIDES IN VITRO. Thrombosis and Haemostasis. 1 indexed citations

17.

Theiss, W & S. Haas. (1986). 93. Grundlagen der physikalischen Thromboseprophylaxe@@@Physical methods of prophylaxis against deep vein thrombosis. Langenbecks Archiv für Chirurgie. 369(1). 459–466.

18.

Theiss, W & S. Haas. (1986). 93. Grundlagen der physikalischen Thromboseprophylaxe. Langenbeck s Archives of Surgery. 369(1). 459–466.

19.

Haas, S., et al.. (1984). The Effect of Aprotinin on Platelet Function, Blood Coagulation and Blood Lactate Level in Total Hip Replacement - A Double Blind Clinical Trial. Advances in experimental medicine and biology. 167. 287–297. 23 indexed citations

20.

Vinazzer, H, A. Stemberger, & S. Haas. (1981). Comparison Between The Action Of Heparin And Of Low Molecular Heparin Analogues On The Hemostatic Mechanism. Thrombosis and Haemostasis. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact